Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice

Catapano, Alberico; Lautsch, Dominik; Tokgozoglu, SADBERK; Ferrieres, Jean; Horack, Martin; Farnier, Michel; Toth, Peter; Brudi, Philippe; Tomassini, Joanne; Ambegaonkar, Baishali; Gitt, Anselm

doi:10.1016/j.atherosclerosis.2016.07.007

Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice

Catapano A. L., Lautsch D., Tokgozoglu L., Ferrieres J., Horack M., Farnier M., ...Daha Fazla

ATHEROSCLEROSIS, cilt.252, ss.1-8, 2016 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 252
Basım Tarihi: 2016
Doi Numarası: 10.1016/j.atherosclerosis.2016.07.007
Dergi Adı: ATHEROSCLEROSIS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1-8
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Hacettepe Üniversitesi Adresli: Evet

Özet

Background and aims: Familial hypercholesterolemia (FH) is a life-threatening disease, characterized by elevated LDL-C levels and a premature, increased risk of coronary heart disease (CHD) that is globally underdiagnosed. The percentage of patients with possible or probable FH in various countries was examined in the Dyslipidemia International Study (DYSIS).